FTC Cleared To Sue Texas Anesthesia Co., But Not PE Firm

By Bryan Koenig · May 14, 2024, 7:01 PM EDT

A Texas federal judge highlighted the limits of the Federal Trade Commission's ability to go after private equity firms accused of anti-competitive "roll-up" strategies, tossing antitrust claims against a private equity...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Federal Trade Commission v. U.S. Anesthesia Partners, Inc. et al

Case Number

Court

Texas Southern

Nature of Suit

Anti-Trust

Date Filed

September 21, 2023

Recent Articles By Bryan

May 22, 2024
Teva, Bristol-Myers Cite Bystolic Against Cancer Drug Case
May 09, 2024
DOJ Task Force To Target Healthcare Monopoly, Collusion
May 07, 2024
$55M Hospital Merger Suit Deal OK'd, UHC Objection Rejected
April 04, 2024
Structure Defense Remains In FTC Hospital Case, But Not Hearing
March 27, 2024
NY AG, Others Blast Sandoz Deal 'Tax' On Future Settlements
March 25, 2024
FTC Intervenes In Teva-Amneal Row To Push Patent Delisting
March 21, 2024
Avoid Major Extension Of Merger Reach, EU High Court Urged
March 19, 2024
Healthcare Provider Says Optum Can't Duck Suit Or Arbitrate
March 18, 2024
2nd Circ. Rejects 'New Standard' Of Patent Monopolies
March 08, 2024
Deadline Drama Briefly Threatens Suit Against Insurer VSP